Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Diabetologists 2017

Sessions/Tracks

Track 1:  Diabetes Pathophysiology

Diabetes usually referred as diabetes mellitus, describes a group of metabolic diseases. Diabetes occurs when there is a dis-balance between the demand and supply of the hormone named insulin. This wide topic is being discussed in ADA Meetings. There are different types of diabetes and all types are treatable and manageable as discussed earlier in European Diabetes Pathophysiology of diabetes leads to autoimmune disease and it’s also known as IDDM, whereas it can also lead to the Peripheral insulin resistance and also known as NIDDM or “adult onset” diabetes. Pathophysiology of gestational diabetes is also one of the types which develop high blood sugar levels in pregnant women who don’t have any previous history of Diabetes. Every few years, the  metabolic syndromes like diabetes is  re-evaluates by community  the present recommendations for the classification, diagnosis, and screening of diabetes, reflecting new info from research and clinical practice which facilitates understanding current hindrance and treatment choices and cost effectiveness in treatment and management of Diabetes as told in ADA Sessions.

Related Conferences:

11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia;  13th Global Diabetes Conference & Medicare Expo, UK ;8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 7th Indo Global Diabetes Summit and Medicare Expo November 23-25, 2015,India;  Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue BiologyFebruary 15-19 2016, Canada; 18th International Conference on Diabetes and Immunology May 23-24 2016, UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue BiologyFebruary 15-19 2016, Canada; ISN World Congress of Nephrology April 21-25 2017, Mexico, Endocrinology Conferences October 10-12, 2016 Manchester, UK.

Related Societies and Association:

American Diabetes Association, USA; Diabetic Association of India, India; Saudi Diabetes and Endocrine Association, Saudi Arabia; Nepal Diabetic Society, Nepal; Australian Diabetes Society, Australia; Diabetes Technology Society, USA; Diabetes Australia, Australia; Austrian Diabetes Association, Austria; Finnish Diabetes Association, Finland; Association of Juvenile Diabetes, USA.

Track 2:  Pediatric Diabetes

Pediatrics is the field of medicine that is concerned with the health of infants, children, and adolescents; their growth and development; and their chance to attain full potential as adults. General medicine includes the essential treatments concerned for the betterment of pediatric health. The most significant problems can be due to nutritional deficiencies to the overall health of infants and kids as a result of growth and development is seriously hindered by shortages in essential vitamins or nutrients. The aim of the study of pediatrics is to reduce infant and child rate of deaths, management the unfold of communicable disease, promote healthy lifestyles for a long disease-free life and help ease the problems of children and adolescents. It can be acknowledged that this can be reached by learning the major and primary subject on Pediatrics.
 

Related Conferences:

Pediatrics Conferences September 14-16, 2016 Amsterdam, The Netherlands; Pediatric Surgery Conferences September 14-16, 2016 Amsterdam, Netherlands; Pediatric Dermatology Conferences October 10-11, 2016 Manchester, UK; Neonatology Conferences November 14-16, 2016 Valencia, Spain; Neonatal Conferences November 14-16, 2016 Valencia, Spain; Pediatric Neurology Conference November 14-16, 2016 Valencia, Spain; 90th Annual Meeting of the Canadian Pediatric Society Jun 22-25 2016 Canada; 28th International Pediatric Association Congress of Pediatrics Aug 17-22 2016, Canada; 2016 American Academy of Pediatrics National Conference & Exhibition October 22-25 2016, USA; 15th Asian Pacific Congress of Pediatrics January 21-24 2016, India; 6th Congress of the European Academy of Pediatric Societies October 21-25 2016, Switzerland.

Related Societies and Association:

International Society for Pediatric and Adolescent Diabetes (ISPAD); British Society for Paediatric Endocrinology and Diabetes, England; Society for Endocrinology, UK; European Society for Paediatric Endocrinology, Europe; American Pediatic Sociaty, USA; Indian Academy of Pediatrics, India.

Track 3:  Symptoms and Management of Diabetes

The supervision of diabetes has been resolutely grounded in scientific advances that endure to stipulate our understanding of the pathophysiology of diabetes and direct our selection in selecting optimal therapies for type 1 and type 2 diabetes. Common risk factors or symptoms of Diabetes include increased weight, blood pressure, cholesterol and triglyceride (blood fat) levels. The main goal of diabetes management is, as far as possible, to restore carbohydrate metabolism to a normal state. To achieve this goal, individuals with an absolute deficiency of insulin require insulin replacement therapy, which is given through injections or an insulin pump. Research on Insulin is extensively discussed in National Diabetes Conference and Diabetes associations.

Related Conferences:

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 11th InternationalConference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 3rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France

Related Societies and Association:

Swiss Diabetes Society, Switzerland; Diabetes UK, UK; Korean Diabetes Association, Korea; Lithuanian Diabetes Association, Lithuana; Luxembourg Diabetes Association, Luxemberg; Maltese Diabetes Association, Malta;Mexican Diabetes Federation, Mexico; IDS Immunology Of Diabetes Society, USA; Philippine Society of Endocrinology and Metabolism, Philippines; Union of Diabetics of Czech Republic, Czech Republic.

Track 4: Diabetes Complications

The Diabetic Complications chiefly includes injurious effects of hyperglycemia which are primarily separated into macro vascular complications and micro vascular complications. Macro vascular complication chiefly includes retinopathy and micro vascular includes neuropathy. Diabetic retinopathy is also the foremost common micro vascular complication of diabetes. It is responsible for ∼ 10,000 new cases of blindness every year in the United States alone. The risk of developing diabetic retinopathy or other micro vascular complications of diabetes depends on both the duration and the severity of hyperglycemia. Diabetic nephropathy is the leading cause of renal failure in the United States. It is defined by proteinuria > 500 mg in 24 hours within the setting of diabetes; however this can be preceded by lower degrees of proteinuria, or “micro albuminuria.

Related Conferences:

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 11th InternationalConference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 3rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France

Related Societies and Association:

Czech Diabetes Society, Czech Republic; Diabetesforeningen, Denmark; Dominican Diabetes Association, Rosesu; National Institute of Diabetes, Dominican Republic; The Egyptian Union of Diabetes Association, Egypt;Estonia Diabetes Association, Estonia; Ethiopian Diabetes Association, Ethiopia; Fiji National Diabetes Foundation, Fiji; Finnish Diabetes Association, Finland; Association Franquise des Diabetiques, France

Track 5: Diabetic Medicare and its Advantages

Diabetic Medicare covers the fasting blood glucose test, which is a diabetes screening. Medicare covers two diabetes screenings each year for beneficiaries who are at high risk for diabetes. High risk factors for diabetes include: high blood pressure, history of abnormal sterol and triglyceride levels, obesity, or a history of high glucose. If this disorder runs in your family, you additionally may also need regular diabetes testing. Diabetic Medicare may include Therapeutic shoe, Glucose control solution or Lancet devices or Lancets as prescribed by your doctor.

Related Conferences:

Diabetes Conferences Europe September 15-17, 2016, Germany; 6th Global Diabetes Summit and Medicare Expo, November 02-04, 2015, UAE; International Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA; 11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia; 9thGlobal Diabetologists Annual Meeting and Medicare Expo, June 06-08, 2016, USA; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE 

Related Societies & Association:

Diabetes Australia (Australia), Austrian Diabetes Association (Austria), Flemish Diabetes Association (Belgium),Canadian Diabetes Association (Canada), French Diabetes Association (French), German Diabetes Union(Germany), Diabetic Society of Singapore (Singapore), Spanish Diabetes Society (Spain), Netherlands Diabetes Association (Netherland), Japan Diabetes Society (Japan), Korean Diabetes society (Korea).

Track 6: Diabetic Nutrition

Diabetic Nutrition or Diabetic diet refers to the diet that is recommended for people with diabetes mellitus, or high blood glucose. There is abundant disagreement relating to what this diet ought to accommodate. Since carbohydrate is the macronutrient which raises blood glucose levels most importantly, the greatest debate is regarding how low in carbohydrates the diet ought to be. This is because although lowering carbohydrate intake will lead to reduced blood glucose levels, but as we know it is the best source of calories too and hence one can improve the health in a big way just by making small changes to the diet, while still enjoying their favorite foods. A diabetes diet is simply a healthy eating plan that is high in nutrients, low in fat, and moderate in calories (carbohydrates too). Manufacturers are now keen towards Diabetes Nutrition on introducing new low calorie food products with sugar substitutes and less oil, in view of the increasing consumer interest toward healthy consumption and facilitate diabetes prevention and its concomitant risk factors.

Related Conferences:

6th Global Diabetes Summit and Medicare Expo, November 02-04, 2015, UAE; International Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA; 11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia; 9th Global Diabetologists Annual Meeting and Medicare Expo, June 06-08, 2016, USA; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics, October 17-19, 2016, Malaysia; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan.

Related Societies & Association:

Canadian Diabetes Association (Canada), Diabetes New Zealand (New Zealand), American Diabetes Association (USA), American Society for Nutrition (USA), Vegetarian Society, Academy of Nutrition and Diabetes, Health Society of South Africa (Africa), Korean Diabetes Association (Korea).

Track 7: Diabetes and Metabolism

The metabolism of individuals with diabetes differs to the metabolism of individuals without it. In type 2 diabetes, the effectiveness of insulin is reduced and in type 1 diabetes, insulin levels in the body are terribly low. For this reason only, type 1 diabetes requires insulin delivery from other strategies. Insulin resistance, commonest in pre-diabetes. Metabolic syndrome and type 2 diabetes, impairs the body’s ability to metabolize glucose. The metabolism of people with diabetes is sort of similar to the metabolism of people without diabetes. The sole distinction is the volume and/or effectiveness of the insulin produced by the body. There is a selected organic process by which insulin is produced inside the body of person.  Insulin therapy is usually recommended for patients with type 2 diabetes mellitus and an initial A1C level greater than 9 percent.  Insulin therapy is also initiated as augmentation, beginning at 0.3 units per kg, or as replacement, beginning at 0.6 to 1.0 units per kg. Glucose control, adverse effects, cost, adherence, and quality of life ought to be thought of once selecting Medicare. Metformin should be continued if possible because it is proven to reduce all-cause mortality and cardiovascular events in overweight patients with diabetes. Titration of insulin over time is critical to improving glycemic management and preventing diabetes related complications.

Related Conferences:

15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; 14th International Conference on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; Diabetes Congress Dubai November 14-16 2016, UAE; International Conference ON Ayurvedic & Herbal Medicine for Diabetes October 9-11 2015, USA; ;  International Conference on Metabolic Syndromes October 17-18, 2016,Italy; Diabetes Conferences Europe September 15-17, 2016, Germany; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Related Societies and Association:

Diabetes Australia (Australia), Austrian Diabetes Association (Austria), Flemish Diabetes Association (Belgium),Canadian Diabetes Association (Canada), French Diabetes Association (French), German Diabetes Union(Germany), Diabetic Society of Singapore (Singapore), Spanish Diabetes Society (Spain), Netherlands Diabetes Association (Netherland), Japan Diabetes Society (Japan), Korean Diabetes society (Korea)

Track 8: Energy Balance, Obesity and Diabetes

A study was done to see the combined effect of the components of energy balance (energy intake and physical activity) and the development of Type 2 Diabetes and the aim of the study is to examine the components of energy balance and the incidence of Type 2 Diabetes in a cohort of middle-aged women. This study was done on a population of 64,227 middle aged Chinese women who don’t have any prior history of Diabetes or any chronic Disease. They collected all the data on diet and physical activity habits and they found that Body Mass index (BMI) and weight gain (since age 20) was strongly associated with type 2 Diabetes incidences. They also concluded that Energy Intake (EI) was associated with modestly increased risk, while physical activity (PA) was associated with decreased risk of type 2 Diabetes, less active women with higher EI and higher risk of type 2 diabetes than active women with lower EI. The EI to PA ratio (EI:PA) was positively associated with Type 2 Diabetes risk. This study suggests that energy balance plays an important role in type 2 Diabetes and this effect may be modified by BMI. 

Related Conference:

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016, Malaysia; 8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 3rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France.

Related Societies & Association:

The obesity society; Diabetes Australia (Australia), Austrian Diabetes Association (Austria), Flemish Diabetes Association (Belgium),Canadian Diabetes Association (Canada), French Diabetes Association (French), German Diabetes Union(Germany), Diabetic Society of Singapore (Singapore), Spanish Diabetes Society (Spain), Netherlands Diabetes Association (Netherland), Japan Diabetes Society (Japan), Korean Diabetes society (Korea)

Track 9: Diabetes Science and Technology

The concept of and new discovery and emerging therapies like  reverse diabetes for the treatment of diabetes has expanded in recent years. There is a lot of latest research on diabetes happening and elaborated at IDF diabetes 2016 and the latest includes some very rare forms of diabetes which are caused by single gene mutations. They are called "monogenic" forms of diabetes and new research is opening the door to specific treatments for these patients. With the advanced  type1 diabetes treatment  various devices e.g. insulin pumps which is used for the administration of insulin , rapid HbA1c monitoring, insulin pen, biomarkers, biostator, artificial pancreas and etc. are formed for the treatment. Number of innovation and treatment are increasing with the increase in research work by Research and development department in various sectors and endocrinology is getting treatment with these devices. Continuous Glucose Monitoring (CGM) is a relatively new technology which has the potential to assist people living with type 1 or type 2 Diabetes and treated with insulin to achieve the goal of optimum control of blood glucose. This will remove the diabetes cholesterol.

Related Conference:

Diabetes Conferences Europe September 15-17, 2016, Germany ; International Conference on AleternativeAyurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference onNutrition and Growth March 17-19 2016, Austria;Diabetes Conferences Europe September 15-17, 2016, Germany, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK.

Related Societies & Association:

Diabetes Technology Society, Burlingame California; Diabetes Australia (Australia), Austrian Diabetes Association (Austria), Flemish Diabetes Association (Belgium),Canadian Diabetes Association (Canada), French Diabetes Association (French), German Diabetes Union(Germany), Diabetic Society of Singapore (Singapore), Spanish Diabetes Society (Spain), Netherlands Diabetes Association (Netherland), Japan Diabetes Society (Japan), Korean Diabetes society (Korea).

Track 10: Diabetic Drug Market

Diabetes Drug Market has grown very rapidly over the time. The Diabetic drug sales of oral glucose- lowering treatments has increased from 10 billion USD TO 15 billion USD from 2005 to 2010 respectively, whereas the market of insulin plus analogues has made a rise to 4 billion USD from the course of 2005 to 2010 while the other drugs made increase of 1 billion USD in the same duration of time. Various companies are manufacturing different drugs for diabetic patients and the health complication caused due to it .Some of the advanced products like insulin pumps, sensors, biomarkers and Innovation seem to be the key to success because it is quite mature and without novel functionality. Tele-medicines and software’s related to increased investments in research and development segment are expected to introduce competitive pharamaceutical products  are discussed at different meetings like scientific sessions at cost effective prices in short time. This latest research on diabetes show as that the diabetes drug market segment would be filled with innovative products that would be able to offer better diabetes management which will protect from swollen pancreas  to patients. Besides all these ayurvedic and herbal medicines were also found effective for the management of Diabetes. Therefore, the various gathering are done in order to protect from metabolic diseases and these gatherings includes the world Diabetes meetings

Related conference:

 Diabetes Conferences Europe September 15-17, 2016, Germany ; International Conference on Alternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolism meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria; Diabetes Conferences Europe September 15-17, 2016, Germany, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK.

Related Societies & Association:

American Diabetes Association, USA; Diabetic Association of India, India; Saudi Diabetes and Endocrine Association, Saudi Arabia; Nepal Diabetic Society, Nepal; Australian Diabetes Society, Australia; Diabetes Technology Society, USA; Diabetes Australia, Australia; Austrian Diabetes Association, Austria; Finnish Diabetes Association, Finland; Association of Juvenile Diabetes, USA.

Track 11: Clinical Trials in Diabetes

Clinical trials are done basically to prevent disease, to develop new and better treatments, or to find a potential cure. A clinical trial is a way to carefully test a new drug or device in patients before it is approved by the FDA to be used in the general public. Clinical trials are an important step in our being able to have new treatments for diabetes and other conditions. American Diabetes Association also provides support in the clinical trials of Diabetes. They different trials for different type of Diabetes is being run here names as TrialNet is basically to delay and reverse the process of Type 1 Diabetes, GRADE is a comparative effectiveness study looking at what medications work best at lowering blood glucose levels in patients who are newly diagnosed with diabetes, RISE (Restoring Insulin Secretion study), D2D (Vitamin D and type 2 diabetes), Accelerating medicines partnership (AMP) and FNIH biomarker Consortium. Many other associations also do diabetic trials for management of Diabetes i.e. Diabetes UK Organization etc.

Related Conference:

4th International Conference on Clinical Trials September 11-13, 2017 San Antonio, USA; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; 14th International Conference on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; Diabetes Congress Dubai November 14-16 2016, UAE;  International Conference on Metabolic Syndromes October 17-18, 2016,Italy; Diabetes Conferences Europe September 15-17, 2016, Germany; Endocrinology Conferences October 10-12, 2016 Manchester, UK.

Related Societies & Association:

Diabetes Australia (Australia), Austrian Diabetes Association (Austria), Flemish Diabetes Association (Belgium),Canadian Diabetes Association (Canada), French Diabetes Association (French), German Diabetes Union(Germany), Diabetic Society of Singapore (Singapore), Spanish Diabetes Society (Spain), Netherlands Diabetes Association (Netherland), Japan Diabetes Society (Japan), Korean Diabetes society (Korea)

Track 12: Diabetes: Research

There is wide research going on in the field of cure, prevention and management of Diabetes. Researchers are trying to develop therapies and drugs which should not create any side effects to the patients of Diabetes. New researches are opening the help door for patients having rare form of Diabetes too for e.g. Diabetes caused by single gene mutations which is called as “monogenic” form of diabetes. They have also created insulin patchesthat imitated the body’s beta cells by both sensing blood glucose level and releasing insulin. Many more researches are going on in the field of Diabetes i.e. Diabetes –depression connection, very low effort muscular activity and Diabetes risk and aerobic exercise improve brain function for people with prediabetes.

Related conference:

15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; 14th International Conference on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; Diabetes Congress Dubai November 14-16 2016, UAE; International Conference on  Ayurvedic & Herbal Medicine for Diabetes October 9-11 2015, USA; ;  International Conference on Metabolic Syndromes October 17-18, 2016,Italy; Diabetes Conferences Europe September 15-17, 2016, Germany; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Related Societies & Association:

American Diabetes Association, USA; Diabetic Association of India, India; Saudi Diabetes and Endocrine Association, Saudi Arabia; Nepal Diabetic Society, Nepal; Australian Diabetes Society, Australia; Diabetes Technology Society, USA; Diabetes Australia, Australia; Austrian Diabetes Association, Austria; Finnish Diabetes Association, Finland; Association of Juvenile Diabetes, USA.

About Conference

After the sucess of Diabetologists 2016, Conference series llc welcomes you to the  "10th Diabetologists Conference" to be held from July 25-27, 2017  in Vancouver, Canada. Diabetologists 2017 will provide an opportunity for  researchers to interact, share new results, show live demonstrations of their work, and discuss about innovative technologies and applications in many fields, including manufacturing techniques, drug administration techniques, drug discovery, drug delivery, product development etc

Theme of  Diabetologists 2017

                                                  “Prevention and Management of Diabetes Through Advanced Technologies”      

With the change in life style, eating habits, environment, the rate of diseases among large population is increasing rapidly. Diabetes is a well-recognized metabolic diseases and well known cause of premature death and disability, increasing the risk of cardiovascular disease, kidney failure, blindness and lower-limb amputation. Diabetes was directly responsible for 1.5 million deaths in 2012 and 89 million DALYs.The global prevalence of Diabetes was estimated to be 9% in 2014. The prevalence of Diabetes was highest in the WHO Region of the Eastern Mediterranean Region (14% for both sexes) and lowest in the European (8% for both sexes) and Western Pacific Regions (9% for both sexes). More than 80% of diabetes deaths occur in low- and middle-income countries. WHO projects that diabetes will be the 7th leading cause of death in 2030.

                                              Therefore , Diabetologists 2017 at Vancouver, Canada from July 25-27, 2017 is going to held at global level.The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions , workshop, symposium etc.

                                .This conference conference includes the renowned scientists, geneticist, microbiologists, doctors, professors, public health planners, physicians, dietitians, pharmacists, students under the research of diabetes, industrial delegates and those using bioinformatics tools for studying under the single roof to discuss and for  improving the current therapies, and exploring radical new approaches.

                                           .

Looking forward to see you  @ Diabetologists 2017

Market Analysis

Summary of Diabetologists Conference

With the change in life style, eating habits, environment, the rate of diseases among large population is increasing rapidly. A disease is a particular abnormal condition or a disorder of that affects part or all of an organisms. In the past few years, Diabetes is emerging very rapidly among the large amount of population. Diabetes at least doubles a person's risk of death. Globally, it has been studied that the number of people with diabetes is expected to rise to 592 million by 2035. Global economic cost of diabetes in 2014 was estimated to be $612 billion. In the United States, diabetes cost $245 billion in 2012.

Importance & Scope:

Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin or alternatively, when the body cannot effectively use the insulin it produces. Elevated blood sugar is a common effect of uncontrolled diabetes and over time can damage the heart, blood vessels, eyes, kidneys, and nerves.

Different types of diabetes include type 1, type 2, Gestational diabetes and diabetes caused due to mutations. Many researcher and experts from different fields like medicine, genetics, immunology, and microbiology are doing research to find the drug with the aim of keeping blood sugar levels as close to normal, without causing low blood sugar. Prevention and management from diabetes are continuously updated by our association and organisation. Therefore, conferences are arranged at global level to discuss and improving the current therapies, and exploring radical new approaches.

Why Canada??

More than 29 million adults and children in the Canada are living with diabetes, and it’s estimated  that an additional 86 million people ages 20 years or older have prediabetes, putting them at increased risk of developing the disease. Vancouver bridges the North American and Asia Pacific regions providing an appropriate setting for discussions on how to tackle the global diabetes epidemic

In order to prevent the people from diabetes and other health complication caused like heart disease, blindness and kidney failure, an international conference is set up at Vancouver, Canada. Vancouver is a major city in Canada and is the largest urban center of the fourth most populous metropolitan area in the Canada.

Conference Highlights:

  • Diabetes Pathophysiology
  • Diagnostics and Clinical Analysis
  • Clinical Case Study
  • Diabetes and complications
  • Diabetic Market Research
  • Diabetes Drug Delivery in Market
  • Diabetes: Prevention and Management
  • Treatment and Therapy
  • Emerging Focus in Diabetes Research
  • Genetics of Diabetes

Why to attend???

Diabetes research involves the experts from different fields, physicians, nurse practitioners, physician’s assistants, nurses, dietitians, pharmacists, and mental health professionals. This conference gives a broad platform to discuss and exchange their ideas and to understand the causes of this disease, major complications, and consequences and well enough to design rational therapies to defeat it. The young researchers and the student participants will gain the opportunity to grab the Best Poster Award by presenting their work as a poster presentation and Young Researcher Forum.

Target Audience:

Global Diabetologists Annual Meeting and Medicare Expo conference includes the renowned scientists, geneticist, microbiologists, doctors, professors, public health planners, physicians, dietitians, pharmacists, students under the research of diabetes, industrial delegates and those using bioinformatics tools for studying under the single roof. The following are the data of audience:

Scientists      60%

Academia    30%

Others          10%

Death causes

According to the survey, it has been seen that the diabetes is one of the danger diseases that is counted in top 10 death causes globally.

World:

USA

Out of 4 people in USA, 1 is affected from diabetes. It has been surveyed that diabetes is listed in top 10 death causes.

Diabetes Scenario

Diabetes has become the seventh leading cause of death and affects 25.8 million people in the United States. The following representation shows the world under effected from the diabetes:

 

 

 

 

Diabetes Association

Different association in world plays a vital role and their mission is to prevent and cure diabetes and to improve the lives of all people affected by disease. There are many associations playing a role in prevention worldwide as well as in countries.

Major Diabetes Associations around the Globe

  •     Diabetes Australia
  •     Austrian Diabetes Association
  •     Flemish Diabetes Association
  •     (Association of Juvenile Diabetes (Brazil)
  •     Canadian Diabetes Association
  •     Juvenile Diabetes Foundation of Chile
  •      Diabetological Colombian Federation
  •     Croatian Diabetes Association
  •     Union of Diabetics of Czech Republic
  •     Estonian Diabetes Association.

 

Major association in USA

  • American Association of Clinical Endocrinologists
  • American Diabetes Association
  • Centers for Disease Control: Division of Diabetes Translation
  • Diabetes Advocacy Alliance
  • Diabetes Hands Foundation
  • Juvenile Diabetes Foundation International
  • National Kidney Foundation
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • International Diabetes Federation
  • Diabetes Association of Atlanta

 

Major association in Dallas

  • American Diabetes Association
  • National Diabetes Association (NDA),US
  • Juvenile Diabetes Research Foundation
  • Joslin Diabetes Center, US
  • Dallas Diabetes And Endocrine Center
  • Centers for Disease Control and Prevention
  • Diabetes health and wellness institutes

                                                       

  Source: Reference 10

Hospitals

USA

With the increasing diabetic patients in USA, the following top 10 hospitals perform the best, house top nursing staffs, deliver quality care and use the most advanced technology.

 

  • Mayo Clinic (Rochester, MN)
  • Cleveland Clinic (Cleveland, OH)
  • Massachusetts General Hospital (Boston, MA)
  • Johns Hopkins Hospital (Baltimore, MD)
  • UCSF Medical Center (San Francisco, CA)
  • New York-Presbyterian University Hospital of Weill Cornell (New York, NY)
  • Yale-New Haven Hospital (New Haven, CT)
  • Northwestern Memorial Hospital (Chicago, IL)
  • UCLA Medical Center (Los Angeles, CA)
  • University of Washington Medical Center (Seattle, WA)

Dallas: Dallas has a total of 186 hospitals having Diabetologists and endocrinology department within 500 miles. Out of these hospitals, 30 are the most highly ranked .Besides these 41 hospitals there are others which rank high for a particular department.

 

                                                   Fig: Hospitals in Dallas

Universities:

The following are the top universities having the diabetologists department:

  • Harvard University
  • University of Oxford
  • University of Cambridge
  • Johns Hopkins University
  • Stanford University
  • Yale University
  • University of California, Los Angeles (UCLA)
  • Imperial College London
  • University of Melbourne
  • Karolinska Institute

Diabetes drugs

There are a number of different types of diabetes drugs - with some having similar ways of acting. The 50+ diabetes drugs available in the world in the form of tablets or injection suspension and placed into different drug’s classes.

Below is the list of different classes of drugs used to treat diabetes:

  • Insulin
  • Biguanides / Metformin
  • Sulphonylureas
  • Meglitinides / Prandial glucose regulator / Glinides
  • Alpha-glucosidase inhibitors
  • Thiazolidinedione / Glitazones
  • DPP-4 inhibitors / Gliptins
  • Incretin mimetics / GLP-1 analogues
  • Amylin analogues

 

Diabetes drugs selling companies

Diabetes is an epidemic in United States that is costing lives and money.  The top 10 best-selling diabetes drugs in the USA are

  • Lantus
  • Januvia
  • NovoLog/NovoRapid
  • Humalog
  • Victoza
  • Levemir
  • Human insulin and devices
  • Janumet
  • NovoMix 30
  • Humulin

 

Fig: Bests diabetic drugs selling companies in world (sales in billion $)

Diabetes at Global Market (2009 – 2016)

The global market for products in the management of diabetes (monitoring, anti-diabetic drugs and insulin) is a $5 billion market currently and is growing at over 9% annually, a rate that is unlikely to slow while rates of obesity prevalence keep climbing.

 

FUND ALLOTMENT

National Institute of Health (NIH) funding for Diabetes (year wise) globally: 

 

Table: Top NIH-funded U.S. Universities

 

 

Companies Associated with Diabetic products and their funding:

 

Statistics of member involved in diabetes:

About 63% members in this world are engaged in diabetes research and out of them 5% members of Dallas are involved.

 

Past Conference Report

Diabetologists 2016

Past Reports  Gallery  

Diabetic Medications-2015

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date July 24-26,2017

For Sponsors & Exhibitors

Speaker Opportunity

Supported By

Journal of Diabetes & Metabolism Pancreatic Disorders & Therapy Journal of Metabolic Syndrome

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by